论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
TREM1 变异对中国汉族人群胶质瘤风险和预后的影响
Authors Hu M, Wei J, Hao J, Jin T, Li B
Received 6 January 2023
Accepted for publication 21 April 2023
Published 3 July 2023 Volume 2023:16 Pages 707—715
DOI https://doi.org/10.2147/PGPM.S403870
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Martin H Bluth
Background: Glioma is the main pathological subtype of brain tumors with high mortality.
Objective: This study aimed to elucidate the correlation between TREM1 variants and glioma risk in the Chinese Han population.
Methods: Genotyping of six variants of TREM1 was completed by Agena MassARRAY platform in 1061 subjects (503 controls and 558 glioma patients). The relationship between TREM1 polymorphisms and glioma risk was calculated using the logistic regression model, with odds ratio (OR) and 95% confidence intervals (CIs). A multifactor dimensionality reduction (MDR) method was performed to assess SNP–SNP interactions to predict glioma risk.
Results: In this research, overall analysis illustrated an association between TREM1 rs9369269 and an increased risk of glioma. Rs9369269 was also related to the risk of glioma in patients aged ≤ 40 years and females. Subjects with rs9369269 AC genotype were likely to obtain glioma compared to people with CC genotype (patients with astroglioma vs healthy people). Compared to TT genotype carriers, carriers with AT genotype of rs1351835 were significantly associated with overall survival (OS).
Conclusion: Taken together, the study identified the association between TREM1 variants and glioma risk and TREM1 variants were significantly associated with the prognosis of glioma. In the future, larger samples are needed to verify the results.
Keywords: glioma, TREM1 , single nucleotide polymorphisms, risk